REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Worldwide Clinical Trials Slovakia S.R.O. (Slovakia)

Main Activities: Management Consulting Services | Administrative Management and General Management Consulting Services
Full name: Worldwide Clinical Trials Slovakia S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Worldwide Clinical Trials Slovakia S.R.O. is a company based in Slovakia, with its head office in Bratislava. It operates in the Management Consulting Services industry. The company was established on July 04, 2009. The company’s latest financial report indicates a net sales revenue increase of 18.71% in 2024. There was a total growth of 3.91% in Worldwide Clinical Trials Slovakia S.R.O.’s total assets over the same period. Worldwide Clinical Trials Slovakia S.R.O.’s net profit margin increased by 2.8% in 2024.

Headquarters
Cintorinska, 7
Bratislava; Bratislavsky; Postal Code: 81108

Contact Details: Purchase the Worldwide Clinical Trials Slovakia S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Worldwide Clinical Trials Slovakia S.R.O. report to view the information.
Financial Auditors:
Purchase the Worldwide Clinical Trials Slovakia S.R.O. report to view the information.
Incorporation Date:
July 04, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Worldwide Clinical Trials Slovakia S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.71%▲
Total operating revenue
18.69%▲
Operating profit (EBIT)
66.5%▲
EBITDA
66.5%▲
Net Profit (Loss) for the Period
272.26%▲
Total Assets
3.91%▲
Total Equity
16.76%▲
Operating Profit Margin (ROS)
1.74%▲
Net Profit Margin
2.8%▲
Return on Equity (ROE)
9.85%▲
Debt/Equity
0.45%▲
Quick Ratio
0.77%▲
Cash Ratio
0.27%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo